You are here: Home
 
Banner
Regional variations in US cancer imaging data: a warning for imaging overuse

Regional variations in US cancer imaging data: a warning for imaging overuse

Danil V Makarov speaks to Gemma Westcott, Commissioning Editor: Danil V Makarov is an Assistant Professor and Director of Surgical Research in the Department o...

SABCS15: ONT-380 Phase I results support progression to Phase II in advanced HER2+ breast cancer

SABCS15: ONT-380 Phase I results support progression to Phase II in advanced HER2+ breast cancer

Phase I data regarding the experimental cancer agent ONT-380 were presented recently at the 2015 San Antonio Breast Cancer Symposium, indicating initial effi...

New Directions in Breast Conserving Surgery – An Interview with Pat Whitworth, MD and Frank Vicini, MD

New Directions in Breast Conserving Surgery – An Interview with Pat Whitworth, MD and Frank Vicini, MD

In this interview, Pat Whitworth, MD, Breast Surgical Oncologist and Director of the Nashville Breast Center in Tennessee (USA), discusses recent advances in...

Banner

Knowledge Bank

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
Save
Cancel
Reset

News

Novartis Entresto given strong Class I recommendation in both US and EU heart failure guidelines, less than a year after regulatory

US guidelines now recommend Entresto as standard of care for HFrEF as an alternative to ACEs or ARBs; call for doctors to switch patients with mild to moderate symptoms to En

Saturday, 21 May 2016 Comments

Press Releases

Anti-Cancer Agent vastin ,Obtained Approval for Additional Indication of Advanced or Recurrent Cervical

Chugai Pharmaceutical Co Ltd announced that it gained approval by the Japanese Ministry of Health, Labour and Welfare (MHLW) on May 23, 2016, for “advanced or recurrent cervical cancer,” as

Monday, 23 May 2016 Comments

Research Insight

Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear

Allergan plc announced that two pivotal trials of the Oculeve Intranasal Tear Neurostimulator, OCUN-009 and OCUN-010, each met their primary and secondary efficacy endpoints. With these new results, a premarket

Monday, 16 May 2016 Comments

Techno Trends

McKesson Launches NEW Drug Spend Intelligence

McKesson announced the launch of its new Drug Spend Intelligence™ tool. Designed by hospital pharmacists, Drug Spend Intelligence is an easy-to-use online tool that provides the information needed to identify

Tuesday, 1 March 2016 Comments

Industry Reports

Merck Increases Sales and Earnings in Q1 Following Sigma-Aldrich

Healthcare and Life Science drive Group organic sales growth (+4.7%) Sigma-Aldrich acquisition fuels sales (+20.5%) and EBITDA pre exceptionals (+27.0%) Integration of Sigma-Aldrich proceeding according to plan Net financial debt lowered by around €

Thursday, 19 May 2016 Comments

Articles

Gastroesophageal Reflux Disease (GERD or

Gastroesophageal Reflux Disease is a condition resulting from stomach acid moving backward from the stomach into the esophagus (the tube that connects the mouth to the stomach). The acid causes

Tuesday, 9 February 2016 Comments

Banner